Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24046 | 23285030 | PLoS One | Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. | 2012 | Details |
| A24059 | 25702427 | Klin Med (Mosk) | [Proinflammatory cytokine levels depending on the stage of hepatic fibrosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2013 | Details |
| A24060 | 25674420 | Springerplus | (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis. | 2013 | Details |
| A24074 | 23262638 | Toxicol Pathol | Toxicant-associated steatohepatitis. | 2012 | Details |
| A24078 | 23258548 | Mol Pharmacol | 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model. | 2012 | Details |
| A24079 | 23258240 | Recenti Prog Med | [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation]. | 2012 | Details |
| A24080 | 23256442 | J Med Food | Dandelion leaf extract protects against liver injury induced by methionine- and choline-deficient diet in mice. | 2012 | Details |
| A24105 | 23226761 | Exp Ther Med | Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice. | 2012 | Details |
| A24109 | 23223552 | JPEN J Parenter Enteral Nutr | A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease. | 2012 | Details |
| A24124 | 23207144 | J Hepatol | Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis. | 2012 | Details |
| A24132 | 23197411 | Gut | Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. | 2012 | Details |
| A24135 | 25755455 | J Clin Exp Hepatol | A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis. | 2012 | Details |
| A24156 | 23174488 | Clin Biochem | Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease. | 2012 | Details |
| A24162 | 23165534 | Nutr Hosp | Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease. | 2013 | Details |
| A24165 | 23159641 | Life Sci | Nonalcoholic fatty liver disease: current and potential therapies. | 2012 | Details |
| A24167 | 23158500 | J Crohns Colitis | Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. | 2012 | Details |
| A24183 | 23142062 | J Hepatol | Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath. | 2012 | Details |
| A24184 | 23141894 | Clin Res Hepatol Gastroenterol | Treatment of NASH with ursodeoxycholic acid: cons. | 2012 | Details |
| A24185 | 23141893 | Clin Res Hepatol Gastroenterol | Treatment of NASH with ursodeoxycholic acid: pro. | 2012 | Details |
| A24186 | 23141876 | Int J Cardiol | Non-alcoholic fatty liver disease and cardiovascular risk. | 2012 | Details |
| A24189 | 23139599 | World J Gastroenterol | Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. | 2012 | Details |
| A24207 | 23123425 | Food Chem Toxicol | Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. | 2012 | Details |
| A24210 | 23118937 | PLoS One | Perinatal exposure to a high-fat diet is associated with reduced hepatic sympathetic innervation in one-year old male Japanese macaques. | 2012 | Details |
| A24217 | 23112047 | J Biol Chem | Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent model. | 2012 | Details |
| A24221 | 23108307 | Dig Dis | Adipocytokines and hepatocellular carcinoma. | 2012 | Details |
| A24223 | 23108115 | J Hepatol | Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. | 2012 | Details |
| A24231 | 23073871 | Intern Emerg Med | Nonalcoholic fatty liver disease and atherosclerosis. | 2012 | Details |
| A24242 | 23085008 | Biochim Biophys Acta | Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity. | 2012 | Details |
| A24244 | 23084643 | Nutr Res | Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. | 2012 | Details |
| A24246 | 23078220 | Can J Physiol Pharmacol | Endurance exercise in a rat model of metabolic syndrome. | 2012 | Details |
| A24254 | 23071295 | J Lipid Res | CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. | 2012 | Details |
| A24259 | 23068074 | Mol Aspects Med | Innate immune activation in obesity. | 2012 | Details |
| A24265 | 23066023 | J Biol Chem | Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. | 2012 | Details |
| A24266 | 23065020 | J Gastroenterol | The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. | 2012 | Details |
| A24274 | 23059407 | J Clin Gastroenterol | Primary biliary cirrhosis is more severe in overweight patients. | 2013 | Details |
| A24278 | 23044079 | Dig Liver Dis | The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product. | 2012 | Details |
| A24286 | 23038002 | J Toxicol Sci | Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models. | 2012 | Details |
| A24322 | 22999247 | Heart Fail Clin | Hepatic and cardiac steatosis: are they coupled? | 2012 | Details |
| A24333 | 22989301 | J Gastroenterol Hepatol | Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model. | 2012 | Details |
| A24343 | 22982943 | Gastroenterology | Sterile inflammation in the liver. | 2012 | Details |
| A24350 | 22978392 | Curr Drug Metab | Fatty acids - induced lipotoxicity and inflammation. | 2012 | Details |
| A24374 | 22960889 | Indian J Med Res | Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease. | 2012 | Details |
| A24384 | 22950794 | Nucleic Acid Ther | Role of regulatory micro RNAs in type 2 diabetes mellitus-related inflammation. | 2012 | Details |
| A24389 | 22942630 | Int J Angiol | Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic Fatty liver disease. | 2011 | Details |
| A24390 | 22941955 | Hepatology | Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. | 2013 | Details |
| A24394 | 22940028 | Phytomedicine | Liv.52 up-regulates cellular antioxidants and increase glucose uptake to circumvent oleic acid induced hepatic steatosis in HepG2 cells. | 2012 | Details |
| A24401 | 22934096 | Front Immunol | Resolution of inflammation in obesity-induced liver disease. | 2012 | Details |
| A24402 | 22934006 | Front Physiol | Liver fibrogenesis in non-alcoholic steatohepatitis. | 2012 | Details |
| A24403 | 22933860 | Gastroenterol Hepatol (N Y) | Hepatitis C virus infection and nonalcoholic steatohepatitis. | 2012 | Details |
| A24405 | 22932913 | Horm Metab Res | Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice. | 2012 | Details |
| A24406 | 22932160 | Eur J Gastroenterol Hepatol | Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. | 2012 | Details |
| A24410 | 22927922 | PLoS One | Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease. | 2012 | Details |
| A24418 | 22919243 | World J Gastroenterol | Efficacy of MK615 for the treatment of patients with liver disorders. | 2012 | Details |
| A24420 | 22915297 | J Nutr | Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. | 2012 | Details |
| A24424 | 22912545 | World J Gastroenterol | Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. | 2012 | Details |
| A24431 | 22902548 | J Hepatol | Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. | 2012 | Details |
| A24446 | 22884488 | Clin Biochem | Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24455 | 22876924 | Curr Med Chem | Adiponectin: key player in the adipose tissue-liver crosstalk. | 2012 | Details |
| A24472 | 22863080 | Liver Int | α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats. | 2012 | Details |
| A24473 | 22858825 | Mol Med Rep | Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c. | 2012 | Details |
| A24475 | 22857151 | Pharm Biol | Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury. | 2012 | Details |
| A24478 | 22855443 | Dongwuxue Yanjiu | [Effects of resistin on hepatic fibrosis: possible mechanisms in non-alcoholic fatty liver disease in in vitro and in vivo]. | 2012 | Details |
| A24481 | 22851489 | J Clin Endocrinol Metab | Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity. | 2012 | Details |
| A24484 | 22848440 | PLoS One | Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24485 | 22847887 | Liver Transpl | Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis. | 2012 | Details |
| A24487 | 22846353 | Clin Calcium | [Magnesium and liver]. | 2012 | Details |
| A24492 | 22843123 | Endocrine | Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. | 2012 | Details |
| A24493 | 22841818 | Am J Pathol | Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease. | 2012 | Details |
| A24511 | 22824479 | Clin Liver Dis | A myriad of pathways to NASH. | 2012 | Details |
| A24540 | 22788090 | Rom J Intern Med | Non-alcoholic fatty liver disease and the statins treatment. | 2012 | Details |
| A24548 | 22768070 | PLoS One | Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice. | 2012 | Details |
| A24554 | 22753133 | Hepatology | Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. | 2012 | Details |
| A24555 | 22751848 | Int J Mol Med | Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis. | 2012 | Details |
| A24556 | 22751700 | Diabetes | Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. | 2012 | Details |
| A24562 | 22749135 | J Nutr Biochem | The role of dietary fatty acids in the pathology of metabolic syndrome. | 2012 | Details |
| A24564 | 22746301 | Curr Drug Metab | Drug disposition in pathophysiological conditions. | 2012 | Details |
| A24567 | 22742899 | Eur J Pharmacol | Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis. | 2012 | Details |
| A24588 | 22720061 | PLoS One | Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice. | 2012 | Details |
| A24597 | 22710359 | Int J Mol Med | Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. | 2012 | Details |
| A24600 | 22706738 | Turk J Gastroenterol | Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats. | 2012 | Details |
| A24601 | 22706383 | Prostaglandins Other Lipid Mediat | Lipidic last breath of life in patients with alcoholic liver disease. | 2012 | Details |
| A24635 | 22672067 | Australas J Dermatol | The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India. | 2012 | Details |
| A24642 | 22658783 | Cytokine | Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24650 | 22648540 | Histol Histopathol | Farnesoid X Receptor (FXR) from normal to malignant state. | 2012 | Details |
| A24655 | 25755424 | J Clin Exp Hepatol | Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis. | 2012 | Details |
| A24666 | 22634121 | J Hepatol | D-livering the message: the importance of vitamin D status in chronic liver disease. | 2012 | Details |
| A24668 | 22633099 | Transl Res | Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. | 2012 | Details |
| A24683 | 22611049 | Hepatology | Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations. | 2012 | Details |
| A24691 | 22594108 | J Tradit Chin Med | Study on effects of zhi zi (fructus gardeniae) on non-alcoholic fatty liver disease in the rat. | 2012 | Details |
| A24692 | 22593713 | ScientificWorldJournal | Deficiency in galectin-3 promotes hepatic injury in CDAA diet-induced nonalcoholic fatty liver disease. | 2012 | Details |
| A24694 | 22589191 | Proteomics | Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet. | 2012 | Details |
| A24701 | 22583683 | Hepatol Res | Suppression of autophagy sensitizes Kupffer cells to endotoxin. | 2012 | Details |
| A24705 | 22577564 | Int J Hepatol | Role of NKT Cells in the Pathogenesis of NAFLD. | 2012 | Details |
| A24711 | 22570770 | J Nutr Metab | Health implications of high dietary omega-6 polyunsaturated Fatty acids. | 2012 | Details |
| A24712 | 22570745 | Gut Liver | NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. | 2012 | Details |
| A24716 | 22569299 | Life Sci | The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model. | 2012 | Details |
| A24727 | 22554516 | Biochem Biophys Res Commun | Ezetimibe reduces fatty acid quantity in liver and decreased inflammatory cell infiltration and improved NASH in medaka model. | 2012 | Details |
| A24741 | 22545719 | Clin Sci (Lond) | Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. | 2012 | Details |
| A24748 | 22540836 | Aliment Pharmacol Ther | Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH). | 2012 | Details |
| A24782 | 22505182 | Int J Mol Med | Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease. | 2012 | Details |